Skip to the page

Data / Form D filings / Inceptive Nucleics, Inc.

Inceptive Nucleics, Inc.: Form D filing

Inceptive Nucleics, Inc., a company in Palo Alto, CA, filed a Form D with the SEC in 2023. The latest, on September 20, 2023, reports $99.7 million sold of a $100 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3160 Porter Drive, Palo Alto, CA, 94304
Phone
(650) 507-4490
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1993343

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 20, 2023New notice$99,999,966$99,699,966$300,0008Sep 6, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jakob UszkoreitExecutive Officer, Director, Promoter
Kevin S. HeyriesExecutive Officer
Vijay S. PandeDirector
Diana Isabel AjuriaExecutive Officer
Do Soon S. KimExecutive Officer

Other companies in California that filed recently

Every Form D from the week of Sep 18, 2023 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Inceptive Nucleics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.